{
  "nctId": "NCT04563754",
  "briefTitle": "The Effectiveness of High Resolution Microendoscopy for People Living With HIV",
  "officialTitle": "The Effectiveness of High Resolution Microendoscopy (HRME) in High Grade Intraepithelial Lesions (HSIL) Diagnosis for People Living With HIV",
  "protocolDocument": {
    "nctId": "NCT04563754",
    "filename": "Prot_SAP_004.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2023-03-24",
    "uploadDate": "2024-12-13T15:25",
    "size": 491018,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT04563754/document/Prot_SAP_004.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "PHASE1",
    "PHASE2"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "NA",
  "interventionModel": "SINGLE_GROUP",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 163,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2019-07-30",
    "completionDate": "2025-03-28",
    "primaryCompletionDate": "2024-03-28",
    "firstSubmitDate": "2020-03-10",
    "firstPostDate": "2020-09-24"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Consentable patients with documented HIV disease\n* Either: 1) previously documented HSIL or 2) abnormal anal cytology within the past 2 years\n* Ages 18 years and older\n* Seen at the Baylor-affiliated Thomas Street Clinic (TSC), Mount Sinai Hospital and affiliated clinics\n\nExclusion Criteria:\n\n* Unable to undergo routine anoscopy\n* Allergy or prior reaction to the fluorescent contrast agent Proflavine or Iodine\n* Unable to give informed consent\n* Current or prior history of Invasive Anal Cancer\n* Known permanent or irreversible bleeding disorder, or other hematologic disorder that in the opinion of the investigator would place the patient at increased risk for adverse outcome from the procedure\n* Pregnancy",
    "healthyVolunteers": true,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Performance Characteristics: Sensitivity (SN), Specificity (SP), Positive Predictive Value (PPV) and Negative Predictive Values (NPV)",
        "description": "The primary outcome of this study is to measure the operating characteristics including SN, SP, PPV and NPV comparing the physician- and algorithm- guided HRME-based image compared to the Lugol's- guided physician diagnosis of HSIL during HRA. Gold standard consensus pathology was used and pathology data needs to be obtained, verified, and entered.",
        "timeFrame": "1 day"
      }
    ],
    "secondary": [
      {
        "measure": "Procedure Efficiency",
        "description": "Diagnostic yield: The number of neoplastic biopsies/total number of biopsies obtained in patients who received biopsies.",
        "timeFrame": "1 day"
      },
      {
        "measure": "Procedure Time",
        "description": "Total procedure time (HRA+HRME+biopsies) vs HRME time alone",
        "timeFrame": "1 day"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 2,
      "otherCount": 0,
      "totalCount": 3
    },
    "studyDesign": {
      "phases": [
        "PHASE1",
        "PHASE2"
      ],
      "isRandomized": false,
      "isMasked": false,
      "interventionModel": "SINGLE_GROUP"
    },
    "overallComplexityScore": 34,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:30:19.484Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}